In-Vitro Release Studies Would Serve As DPK Adjunct Under FDA Proposal
Executive Summary
In-vitro drug release studies should be required as an adjunct to dermatopharmacokinetics for establishing the bioequivalence of topical dermatological products, under FDA proposed changes to a draft guidance.